Our use of cookies
We would like to use necessary cookies to perform the basic functions of this website. Such strictly necessary cookies do not require your consent and are therefore always active. We would also like to set analytical cookies and advertising cookies that help us make improvements by measuring how you use our website. Both the analytical cookies and advertising cookies require your consent and are therefore called “optional cookies”. Detailed information about the use of cookies and how you can control your consent for optional cookies can be found in our Cookie Policy and Privacy Policy.

Hello! We use cookies to help improve your experience of our website. With your consent, statistical and analytical cookies may also be used on this website. If you agree to the use of these additional cookies, please mark your choice:
cLTbk7uxvQeTnrfxsZFsdK6Km5SkGXbhLJR9VbqT.webp

27.04 - 30.04.2024

MGI Showcases Life Science Excellence at ESCMID Global 2024 with Latest DNBSEQ-E25 Sequencer and New Partnership with ABL Diagnostics

MGI debuts DNBSEQ-E25, a portable sequencer, and announces collaboration with ABL Diagnostics for microbiology genotyping at ESCMID Global 2024.

Yfsu7FlXPnzZIUhw4i295cjVdBjXqjHtLi40DEsJ.png

19.03.2024

Exciting Partnership Announcement: MGI and Lexogen Collaborate to Validate QuantSeq and CORALL Libraries on DNBSEQ™ Technology

lwf8f2bofUlS5Mqg2CwJyANplw5KrLKwSgmBrze1.png

04.03.2024

Elevating Precision Health: MGI Tech and Eurofins Genomics Unite with DNBSEQ-T20×2 Sequencer

MGI Tech has joined forces with Eurofins Genomics Europe Genotyping A/S, marking a pivotal moment in the advancement of large-scale genomic projects. This partnership heralds the first corporate order of the DNBSEQ-T20×2 ("T20") ultra-high throughput sequencer in Europe.

mhZmVDmew3XFNhOPbUQ67BkiLVvM1daMDW71RL0a.png

10.11 - 11.11.2023

Latvia MGI Tech SIA Advances DNA Methylation Research with Significant European Funding

Latvia MGI Tech SIA advances DNA methylation research with significant European funding, achieving groundbreaking progress in biotechnology and innovation

H6JF21FpSTSqgGV5XcsI0pEW0wmDB03WrQEADlwr.png

10.07.2023

MGI's DNBSEQ-T20*x2 Wins 2023 Globee® Awards for Medical Equipment

Explore MGI's latest achievement as its DNBSEQ-T20×2 gene sequencing platform wins the prestigious Globee® for Medical Equipment in the 15th Annual 2023 Golden Bridge Business and Innovation Awards®. This post highlights MGI's commitment to innovation in the life science industry, their groundbreaking T20 gene sequencer, and how their technology is reshaping healthcare outcomes and the genetic industry.

tee273xLNe5MxMB1M5HxuFKGYQkhuK4KthVmXMGS.jpg

14.06.2023

Unveiling MGI's Groundbreaking Innovations at the ESHG Conference in Glasgow

Discover the groundbreaking partnerships and innovations unveiled by MGI Tech Co., Ltd. at the ESHG Conference in Glasgow. Learn about MGI's strategic collaborations in the European life sciences market, their advancements in sequencing and automation technologies, and their commitment to revolutionizing genomics research. This post also highlights MGI's strategic partnership with Alithea Genomics, aiming to innovate in RNA sequencing.